This inventor holds 2 USPTO granted patents. Top assignees: The United States of America as Represented by the Secretary of, The United States of America as Represented by the Secretary, Department. Active years: 1995-1997.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 1995-1997
Title: Guido Francois: Innovator in Antimalarial Compounds
Introduction
Guido Francois is a notable inventor based in Oostende, Belgium. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimalarial compounds. With a total of 2 patents, his work focuses on innovative solutions for combating malaria infections.
Latest Patents
Francois's latest patents include groundbreaking research on antimalarial naphthylisoquinoline alkaloids. This invention provides pharmaceutical compositions that contain these alkaloids, which are useful in preventing and treating malaria infections in mammals. The compounds developed by Francois inhibit the reproduction and cytopathicity of Plasmodium sp. parasites both in vitro and in vivo. Another significant patent involves the discovery of korupensamines, new antimalarial compounds derived from the plant Ancistrocladus korupensis. This patent outlines methods for isolating these compounds and their derivatives, as well as their applications in treating malaria.
Career Highlights
Throughout his career, Francois has worked with various organizations, including the United States of America as represented by the Secretary of the Department. His innovative research has positioned him as a key figure in the fight against malaria.
Collaborations
Francois has collaborated with esteemed colleagues such as Gerhard Bringmann and Michael R Boyd. Their combined expertise has contributed to the advancement of antimalarial research and the development of effective pharmaceutical solutions.
Conclusion
Guido Francois's contributions to the field of antimalarial compounds highlight his dedication to improving public health. His innovative patents and collaborations reflect a commitment to finding effective treatments for malaria infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile